Toxicological Emergencies

References

  1. “Definition of Drug.” Merriam-Webster, Merriam-Webster, https://www.merriam-webster.com/dictionary/drug.  Accessed June 2019.
  2. “Reports to U.S. Poison Control Centers.” Poison Statistics National Data 2017, Poison Control, 2017, https://www.poison.org/poison-statistics-national.
  3. https://www.drugabuse.gov/publications/research-reports/hallucinogens-dissociative-drugs/what-are-dissociative-drugs
  4. “Protecting Kids from Environmental Exposure.” Centers for Disease Control and Prevention, U.S. Department of Health & Human Services.Centers for Disease Control and Prevention, 7 Oct. 2019, https://www.cdc.gov/features/pehsu/.
  5. Karb, Rebecca. “American College of Emergency Physicians.” ACEP // Home Page, American College of Emergency Physicians, https://www.acep.org/how-we-serve/sections/toxicology/news/march-2016/one-pill-or-sip-can-kill/.
  6. Vo KT, Horng H, Li K, et al. Cannabis Intoxication Case Series: The Dangers of Edibles Containing Tetrahydrocannabinol. Ann Emerg Med 2018; 71:306.
  7. Devine ML, Dow GJ, Greenberg BR, et al. Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study. Clin Pharm 1987; 6:319.
  8. Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996; 91:1585.
  9. Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 2013; 33:195.
  10. Appelboam A, Oades PJ. Coma due to cannabis toxicity in an infant. Eur J Emerg Med 2006; 13:177.
  11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/pdf/nihms353647.pdf
  12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576702/pdf/nihms353647.pdf
  13. Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA 1998; 280:1936.
  14. Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001; 178:101.
  15. https://www.vbems.com/2018/07/19/miosis-differential-diagnosis-causes/
  16. Charney, DS, Minic, SJ, Harris, RA. Hypnotics and sedatives. In: Hardman, JG, Limbird, LE (Eds), Goodman and Gilman's: The pharmacological basis of therapeutics, 10th ed, McGraw-Hill, New York 2001. p.399.
  17. Medical Curiosities. Youngson, Robert M. London: Robinson Publishing, 1997. Page 276.
  18. Sneader, Walter (2005-06-23). Drug Discovery. John Wiley and Sons. pp. 369.
  19. Abuse of benzodiazepines: The problems and the solutions. A report of a Committee of the Institute for Behavior and Health, Inc. Am J Drug Alcohol Abuse 1988; 14 (Suppl 1):1.
  20. Sussman, N, Stein, DJ. Pharmacotherapy for generalized anxiety disorder. In: Stein, DJ, Hollander, E (Eds), Textbook of anxiety disorders, American Psychiatric Press, Washington, DC 2002. p.135.
  21. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007; 64:830.
  22. Dawson, D.A.; Goldstein, R.B.; Saha, T.D.; and Grant, B.F. Changes in alcohol consumption: United States, 2001-2002 to 2012-2013. Drug and Alcohol Dependence 148:56–61, 2015. PMID: 25620731. Reprinted from the NIAAA Spectrum, Volume 8, Issue 1, June 2016.
  23. https://www.who.int/news-room/fact-sheets/detail/alcohol
  24. O'Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med 1998; 338:592. 18582     690        
  25.  Savage D, Lindenbaum J. Anemia in alcoholics. Medicine (Baltimore) 1986; 65:322.
  26. Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med 2005; 352:596.
  27. https://www.cdc.gov/chronicdisease/resources/publications/factsheets/alcohol.htm
  28. https://archives.fbi.gov/archives/about-us/lab/forensic-science-communications/fsc/jan2002/hornfelt.htm
  29. Okun, M. S., Doering, P. L., Bartfield, R. B. GHB toxicity: what you need to know. Emerg Med 2000 Dec:10-23.
  30. Galloway, G. P., Frederick-Osborne, S. L., Seymour, R., Contini, S. E., Smith, D. E. Abuse and therapeutic potential of gamma-hydroxybutyric acid. Alcohol 2000 Apr;20(3):263-9
  31. Li, J., Stokes, S. A., Woeckener, A. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management. Ann Emerg Med 1998 Jun;31(6):729-36
  32. Shannon, M., Quang, L. S. Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature. Pediatr Emerg Care 2000 Dec;16(6):435-40
  33.  Ross EA, Watson M, Goldberger B (2011). ""Bath Salts" Intoxication". New England Journal of Medicine 365 (10): 967–968.
  34. Goss J., Designer drugs. JEMS 2001 Jun:84-93
  35. Braback L., Humble M.. MDMA. Lakartidningen 2001 Feb 21;98(8):817-9
  36.  Duflou, J., Mark, A. Aortic dissection after ingestion of "ecstasy" (MDMA). Am J Forensic Med Pathol 2000 Sep;21(3):261-3
  37.  Liberg, J. P., Hovda, K.E., Nordby, G., Jacobsen, D. Ecstasy--cool dope with long-lasting effects. Tidsskr Nor Laegeforen 1998 Nov 20;118(28):4384-7
  38. Evanko, D. 'Designer drugs'. Treating the damage caused by basement chemists. Postgrad Med 1991 May 1;89(6):67-71
  39. https://www.drugabuse.gov/sites/default/files/podat_1.pdf
  40. Sperling LS, Horowitz JL. Methamphetamine-induced choreoathetosis and rhabdomyolysis. Ann Intern Med 1994; 121:986.
  41. Alldredge BK, Lowenstein DH, Simon RP. Seizures associated with recreational drug abuse. Neurology 1989; 39:1037.
  42. Zweben JE, Cohen JB, Christian D, et al. Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13:181.
  43. Howcast.  “What the THC & CPD? | Marijuana” Youtube. February 23, 2013. 3:17.  https://www.youtube.com/watch?v=8ZqVx1M3daQ
  44. Leafly. “Ingest or inhale? 5 differences between cannabis edibles and flowers.”  Bailey Rahn. July 17, 2014 https://www.leafly.com/news/cannabis-101/differences-between-marijuana-edibles-and-flower
  45. https://www.cdc.gov/drugoverdose/epidemic/index.html
  46. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHDetailedTabs2017/NSDUHDetailedTabs2017.pdf
  47. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf